JPMorgan Chase Financial Company LLC filed a Free Writing Prospectus on November 9, 2026, disclosing the preliminary terms of two-year, non-callable-for-six-months Auto Callable Contingent Interest Notes linked to the Nasdaq-100, Russell 2000, and S&P 500 indexes, with a pricing date of November 24, 2026.
JPMorgan Chase Financial Company LLC filed a Free Writing Prospectus on November 9, 2026, disclosing terms for 3-year non-call 6-month Auto Callable Contingent Interest Notes linked to the Nasdaq-100 Index, Russell 2000 Index, and S&P 500 Index, with a pricing date of November 24, …
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) on November 9, 2026, disclosing terms for 2-year non-callable-for-six-months Auto Callable Contingent Interest Notes linked to the Nasdaq-100 Index, Russell 2000 Index, and S&P 500 Index, with a pricing date of November 30, …
JPMorgan Chase Financial Company LLC filed a free writing prospectus on November 9, 2026, disclosing the preliminary terms of 18-month autocallable contingent interest notes linked to the Nasdaq-100 Index, Russell 2000 Index, and S&P 500 Index, with a pricing date of November 24, 2026.
JPMorgan Chase Financial Company LLC filed a free writing prospectus on November 9, 2026, disclosing the preliminary terms of 3-year non-call 6-month auto callable contingent interest notes linked to the Nasdaq-100 Index, Russell 2000 Index, and S&P 500 Index, with a pricing date of …
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed Amendment No. 2 to a Schedule 13G with the SEC on October 8, 2026, disclosing zero beneficial ownership of Chart Industries, Inc. common stock as of September 30, 2026.
HSBC Holdings plc filed a Form 6-K on November 9, 2026, disclosing the purchase for cancellation of ordinary shares on UK venues and the Hong Kong Stock Exchange as part of the buy-back announced on October 28, 2026.
Coastlands Capital LP and related entities filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 852,669 shares of Sutro Biopharma, Inc. common stock, representing 5.14% of the outstanding class, as of a triggering event dated November 5, 2026.
BofA Finance LLC filed a free writing prospectus on November 9, 2026, disclosing preliminary terms for Accelerated Return Notes linked to the iShares U.S. Aerospace & Defense ETF, with final terms to be set on the pricing date.
Patrick S. Watson, Vice President and CFO of Kennametal Inc., filed a Form 4 on November 9, 2026, disclosing a purchase of 2,000 shares of Kennametal common stock on November 6, 2026.